Suchergebnisse - "Bruce, I N"

PubPharm (7)

1

Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients

enthalten in: The pharmacogenomics journal | 2013

von Owen, S. | Hider, S. | Martin, P. | +3

2

MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis : analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms

enthalten in: The pharmacogenomics journal | 2013

von Owen, S. | Lunt, M. | Bowes, J. | +4

3

Testing pharmacogenetic indices to predict efficacy and toxicity of methotrexate monotherapy in a rheumatoid arthritis patient cohort

enthalten in: Arthritis and rheumatism | 2010

von Owen, S. | Lunt, M. | Hider, S. | +3

4

Polymorphisms within the adenosine receptor 2a gene are associated with adverse events in RA patients treated with MTX

enthalten in: Rheumatology (Oxford, England) | 2008

von Hider, S. | Thomson, W. | Mack, L. | +3

5

The pharmacogenetics of methotrexate

enthalten in: Rheumatology (Oxford, England) | 2007

von Hider, S. | Bruce, I. | Thomson, W.

CommentIn: Rheumatology (Oxford). 2008 Apr;47(4):557; author reply 5557-8. - PMID 18222982

6

Down regulation of multidrug resistance protein-1 expression in patients with early rheumatoid arthritis exposed to methotrexate as a first disease-modifying antirheumatic drug

enthalten in: Annals of the rheumatic diseases | 2006

von Hider, S. | Owen, A. | Hartkoorn, R. | +4

7

Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with RA?

enthalten in: Annals of the rheumatic diseases | 2003

von Hider, S. | Morgan, C. | Bell, E. | +1

CommentOn: Ann Rheum Dis. 2003 Jan;62(1):4-9. - PMID 12480661

1
[1]